Cohan, S. L., Edwards, K., Lucas, L., Gervasi-Follmar, T., O’Connor, J., Siuta, J., . . . Spinelli, K. J. (2019). Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy. Mult Scler J Exp Transl Clin.
Chicago Style CitationCohan, Stanley L., et al. "Reducing Return of Disease Activity in Patients With Relapsing Multiple Sclerosis Transitioned From Natalizumab to Teriflunomide: 12-month Interim Results of Teriflunomide Therapy." Mult Scler J Exp Transl Clin 2019.
Cita MLACohan, Stanley L., et al. "Reducing Return of Disease Activity in Patients With Relapsing Multiple Sclerosis Transitioned From Natalizumab to Teriflunomide: 12-month Interim Results of Teriflunomide Therapy." Mult Scler J Exp Transl Clin 2019.